CVE-2023-26099: Telindus Apsal

High severity, CVSS 7.1. EPSS: 0.2% chance of exploitation in the next 30 days.

An issue was discovered in Telindus Apsal 3.14.2022.235 b. The consultation permission is insecure.

Affected products

• Telindus Apsal: version 3.14.2022.235_b only

Published 2023-04-24. Last modified 2026-06-17.